INSIGHTS ON CLINICAL TRIAL DESIGN
-
Recruitment Readiness: From The Front Lines To First-In-Patient
Operating within local markets, LES professionals conduct meticulous eligibility assessments, manage referrals, and facilitate patient navigation, ensuring a seamless pre-screening experience.
-
How Protocol Design Decisions Shape Recruitment, Data Quality & Study Startup
Protocol design directly affects recruitment, data quality, and startup speed. Clear workflows, streamlined criteria, and early alignment reduce delays, amendments, and improve reliable study execution.
-
From Chaos To Clarity: A Founder's View From 30 Years In Drug Development
Same workflows, higher stakes. A 30-year drug development veteran reveals how outdated sample handling puts trial outcomes at risk and what sponsors can do about it.
-
Why Bioanalysis Needs To Break Free From Manual Bottlenecks
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
-
DCTs And Community-Based Research Execution And Compliance5/28/2025
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
Migrating A Live Personalized Medicine Trial To Next-Gen RTSM3/26/2026
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
Retention And Access In NSCLC Clinical Trials5/12/2026
Helping participants navigate respiratory limitations, fatigue, and complex visit schedules in Non-Small Cell Lung Cancer (NSCLC) studies.
-
Gene, Cell, And RNA Therapy Landscape Continues To Thrive3/21/2025
The horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.
-
Why Amendments Break Trials and How Elosity R3 Fixes It7/31/2026
Protocol amendments are inevitable. The challenge is managing them without disrupting trial execution.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Accelerate study start-up with the right sites, patients, and partnerships
As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.
-
TrialScope Disclose delivers the proven solutions clinical trial sponsors need to centralize, track, register, and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.
-
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
-
Enable consistent protocol execution with standardized workflows for training, monitoring, documentation, inventory, and drug accountability.
-
Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.